| Streptococcus iniae | |
|---|---|
| |
| Phase contrast micrograph of S. iniae colonies stained with streptavidin-FITC | |
Scientific classification 
| |
| Domain: | Bacteria |
| Phylum: | Bacillota |
| Class: | Bacilli |
| Order: | Lactobacillales |
| Family: | Streptococcaceae |
| Genus: | Streptococcus |
| Species: | S. iniae
|
| Binomial name | |
| Streptococcus iniae Pier, 1976[1]
| |
| Synonyms | |
|
Streptococcus shiloi (Eldar, 1994) | |
Streptococcus iniae is a species of Gram-positive, sphere-shaped bacterium belonging to the genus Streptococcus. Since its isolation from an Amazon freshwater dolphin in the 1970s, S. iniae has emerged as a leading fish pathogen in aquaculture operations worldwide, resulting in over US$100M in annual losses. Since its discovery, S. iniae infections have been reported in at least 27 species of cultured or wild fish from around the world. Freshwater and saltwater fish including tilapia, red drum, hybrid striped bass, and rainbow trout are among those susceptible to infection by S. iniae. Infections in fish manifest as meningoencephalitis, skin lesions, and septicemia.
S. iniae has occasionally produced infection in humans, especially fish handlers of Asian descent. Human infections include sepsis, toxic shock syndrome, and inflammation of the skin, intervertebral discs, or inner layer of the heart. Identifying S. iniae in the laboratory can be difficult, since the conventional methods used to identify streptococci yield insufficient results. It cannot be grouped by the Lancefield antigen method typically used to categorize Streptococcus species. The two known serotypes can be distinguished biochemically by differences in enzyme activity. Several antibiotics have been used to treat S. iniae infections.